AgenciesBharat Biotech on Tuesday said it expects approval for its COVID-19 vaccine Covaxin from the World Health Organisation for Emergency Use Listing during July-September.
The company said regulatory approvals for Covaxin are in process in more than 60 countries, including the USA, Brazil and Hungary, among others.
"Application for EUL has been submitted to WHO-Geneva. Regulatory approvals are expected July-September 2021," it said in a release.
The city based vaccine maker said it has got EUA in 13 countries with more to follow.
Most countries recommend vaccinations against COVID-19.
Unvaccinated travelers can travel with negative RT-PCR tests prior to travel, in the absence of any other country specific travel restrictions, Bharat Biotech said.
The company said regulatory approvals for Covaxin are in process in more than 60 countries, including the USA, Brazil and Hungary, among others.
"Application for EUL has been submitted to WHO-Geneva. Regulatory approvals are expected July-September 2021," it said in a release.
The city based vaccine maker said it has got EUA in 13 countries with more to follow.
Most countries recommend vaccinations against COVID-19.
Unvaccinated travelers can travel with negative RT-PCR tests prior to travel, in the absence of any other country specific travel restrictions, Bharat Biotech said.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.